Table 3.
Molecular mechanism of neuroprotection by Sch B.
Assay | Organism tested | Dose/conc. | Mechanisms | References |
---|---|---|---|---|
Sch B prevents neuron from Alzheimer's disease | Mice | 340, 290, 80, and 70 nM | Inhibited glycogen synthase kinase-3β, therefore alleviating the cell injury induced by Aβ and the cognitive disorders in AD | [65] |
Sch B prevents neurodegenerence induced by anxiety associated with oxidative stress | Mice | 30 mg/kg and 60 mg/kg | Increase the activity of SOD, GSH, and Nrf2 and Keap1, along with suppression of ROS production | [63] |
Sch B might improve Parkinson's disease | Mice | 100 μM | Improve 6-OHDA-induced neural cell death and activated Nrf2 signaling pathways along with boosting the expression of miR-34a. Those protect from neurodegenerence | [64] |
Sch B prevents cerebral ischemia | Sprague-Dawley rats | 10 and 30 mg/kg | Inhibited the expression of proinflammatory factor (TNF-α and IL-1β) as well as prevented the activation of MMP2/9 | [60] |